Search COVID-19 Rapid Resource Center or explore resources sorted by Category or Content Type.


Subcutaneous Enoxaparin Safely Facilitates Bedside Sustained Low-Efficiency Hemodialysis in Hypercoagulopathic Coronavirus Disease 2019 Patients - A Proof-of-Principle Trial

This study describes a simple and safe protocol of anticoagulation with low molecular weight heparin (LMWH) in combination with bedside sustained low efficiency hemodialysis (SLED) in COVID-19 patients.

Authors: Neumann-Haefelin E, Widmeier E, Bansbach J, et al. Crit Care Explor 2020.


Estimated Time: 09:16 min

Categories: Disaster, Hematology, Pharmacology,
Content Type: Articles,